 | • レポートコード：MRC2Q12-16827 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ポイントオブケア分子診断技術のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ポイントオブケア分子診断技術のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ポイントオブケア分子診断技術の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ポイントオブケア分子診断技術のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのポイントオブケア分子診断技術の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のポイントオブケア分子診断技術の売上および2028年までの予測に焦点を当てています。 ポイントオブケア分子診断技術のグローバル主要企業には、Abbott、Accelerate Diagnostics、Ador Diagnostics、Beckman Coulter、Becton, Dickinson and Company、Binx Health、Biocartis、bioMérieux、Bio-Rad Laboratories、Bosch Healthcare Solutions、Curetis、Eurofins Scientific、Genetic Signatures、Grifols、Hibergene Diagnostics、Lumos Diagnostics、Roche、Siemens、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ポイントオブケア分子診断技術市場は、タイプとアプリケーションによって区分されます。世界のポイントオブケア分子診断技術市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ポリメラーゼ連鎖反応、in situ ハイブリダイゼーション、遺伝子チップ、次世代シーケンシング 【アプリケーション別セグメント】 病院/クリニック、独立型臨床検査室 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ポイントオブケア分子診断技術製品概要 - タイプ別市場（ポリメラーゼ連鎖反応、in situ ハイブリダイゼーション、遺伝子チップ、次世代シーケンシング） - アプリケーション別市場（病院/クリニック、独立型臨床検査室） - 調査の目的 ・エグゼクティブサマリー - 世界のポイントオブケア分子診断技術販売量予測2017-2028 - 世界のポイントオブケア分子診断技術売上予測2017-2028 - ポイントオブケア分子診断技術の地域別販売量 - ポイントオブケア分子診断技術の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ポイントオブケア分子診断技術販売量 - 主要メーカー別ポイントオブケア分子診断技術売上 - 主要メーカー別ポイントオブケア分子診断技術価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ポリメラーゼ連鎖反応、in situ ハイブリダイゼーション、遺伝子チップ、次世代シーケンシング） - ポイントオブケア分子診断技術のタイプ別販売量 - ポイントオブケア分子診断技術のタイプ別売上 - ポイントオブケア分子診断技術のタイプ別価格 ・アプリケーション別市場規模（病院/クリニック、独立型臨床検査室） - ポイントオブケア分子診断技術のアプリケーション別販売量 - ポイントオブケア分子診断技術のアプリケーション別売上 - ポイントオブケア分子診断技術のアプリケーション別価格 ・北米市場 - 北米のポイントオブケア分子診断技術市場規模（タイプ別、アプリケーション別） - 主要国別のポイントオブケア分子診断技術市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのポイントオブケア分子診断技術市場規模（タイプ別、アプリケーション別） - 主要国別のポイントオブケア分子診断技術市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のポイントオブケア分子診断技術市場規模（タイプ別、アプリケーション別） - 主要国別のポイントオブケア分子診断技術市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のポイントオブケア分子診断技術市場規模（タイプ別、アプリケーション別） - 主要国別のポイントオブケア分子診断技術市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのポイントオブケア分子診断技術市場規模（タイプ別、アプリケーション別） - 主要国別のポイントオブケア分子診断技術市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、Accelerate Diagnostics、Ador Diagnostics、Beckman Coulter、Becton, Dickinson and Company、Binx Health、Biocartis、bioMérieux、Bio-Rad Laboratories、Bosch Healthcare Solutions、Curetis、Eurofins Scientific、Genetic Signatures、Grifols、Hibergene Diagnostics、Lumos Diagnostics、Roche、Siemens、Thermo Fisher Scientific ・産業チェーン及び販売チャネル分析 - ポイントオブケア分子診断技術の産業チェーン分析 - ポイントオブケア分子診断技術の原材料 - ポイントオブケア分子診断技術の生産プロセス - ポイントオブケア分子診断技術の販売及びマーケティング - ポイントオブケア分子診断技術の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ポイントオブケア分子診断技術の産業動向 - ポイントオブケア分子診断技術のマーケットドライバー - ポイントオブケア分子診断技術の課題 - ポイントオブケア分子診断技術の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Point of Care Molecular Diagnostics Technology estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Point of Care Molecular Diagnostics Technology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Point of Care Molecular Diagnostics Technology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Point of Care Molecular Diagnostics Technology is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Point of Care Molecular Diagnostics Technology include Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioMérieux and Bio-Rad Laboratories, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Point of Care Molecular Diagnostics Technology companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Point of Care Molecular Diagnostics Technology market. Further, it explains the major drivers and regional dynamics of the global Point of Care Molecular Diagnostics Technology market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton, Dickinson and Company
Binx Health
Biocartis
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Point of Care Molecular Diagnostics Technology Segment by Type
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Point of Care Molecular Diagnostics Technology Segment by Application
Hospitals and Clinics
Independent Clinical Laboratories
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Point of Care Molecular Diagnostics Technology market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Point of Care Molecular Diagnostics Technology market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Point of Care Molecular Diagnostics Technology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Point of Care Molecular Diagnostics Technology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Point of Care Molecular Diagnostics Technology revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Point of Care Molecular Diagnostics Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Point of Care Molecular Diagnostics Technology revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioMérieux and Bio-Rad Laboratories, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Point of Care Molecular Diagnostics Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care Molecular Diagnostics Technology companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Point of Care Molecular Diagnostics Technology revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polymerase Chain Reaction
1.2.3 In Situ Hybridization
1.2.4 Gene Chips
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Independent Clinical Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Molecular Diagnostics Technology Market Perspective (2017-2028)
2.2 Point of Care Molecular Diagnostics Technology Growth Trends by Region
2.2.1 Point of Care Molecular Diagnostics Technology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Point of Care Molecular Diagnostics Technology Historic Market Size by Region (2017-2022)
2.2.3 Point of Care Molecular Diagnostics Technology Forecasted Market Size by Region (2023-2028)
2.3 Point of Care Molecular Diagnostics Technology Market Dynamics
2.3.1 Point of Care Molecular Diagnostics Technology Industry Trends
2.3.2 Point of Care Molecular Diagnostics Technology Market Drivers
2.3.3 Point of Care Molecular Diagnostics Technology Market Challenges
2.3.4 Point of Care Molecular Diagnostics Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Molecular Diagnostics Technology Players by Revenue
3.1.1 Global Top Point of Care Molecular Diagnostics Technology Players by Revenue (2017-2022)
3.1.2 Global Point of Care Molecular Diagnostics Technology Revenue Market Share by Players (2017-2022)
3.2 Global Point of Care Molecular Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Molecular Diagnostics Technology Revenue
3.4 Global Point of Care Molecular Diagnostics Technology Market Concentration Ratio
3.4.1 Global Point of Care Molecular Diagnostics Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Molecular Diagnostics Technology Revenue in 2021
3.5 Point of Care Molecular Diagnostics Technology Key Players Head office and Area Served
3.6 Key Players Point of Care Molecular Diagnostics Technology Product Solution and Service
3.7 Date of Enter into Point of Care Molecular Diagnostics Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Molecular Diagnostics Technology Breakdown Data by Type
4.1 Global Point of Care Molecular Diagnostics Technology Historic Market Size by Type (2017-2022)
4.2 Global Point of Care Molecular Diagnostics Technology Forecasted Market Size by Type (2023-2028)
5 Point of Care Molecular Diagnostics Technology Breakdown Data by Application
5.1 Global Point of Care Molecular Diagnostics Technology Historic Market Size by Application (2017-2022)
5.2 Global Point of Care Molecular Diagnostics Technology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
6.2 North America Point of Care Molecular Diagnostics Technology Market Size by Type
6.2.1 North America Point of Care Molecular Diagnostics Technology Market Size by Type (2017-2022)
6.2.2 North America Point of Care Molecular Diagnostics Technology Market Size by Type (2023-2028)
6.2.3 North America Point of Care Molecular Diagnostics Technology Market Share by Type (2017-2028)
6.3 North America Point of Care Molecular Diagnostics Technology Market Size by Application
6.3.1 North America Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2022)
6.3.2 North America Point of Care Molecular Diagnostics Technology Market Size by Application (2023-2028)
6.3.3 North America Point of Care Molecular Diagnostics Technology Market Share by Application (2017-2028)
6.4 North America Point of Care Molecular Diagnostics Technology Market Size by Country
6.4.1 North America Point of Care Molecular Diagnostics Technology Market Size by Country (2017-2022)
6.4.2 North America Point of Care Molecular Diagnostics Technology Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
7.2 Europe Point of Care Molecular Diagnostics Technology Market Size by Type
7.2.1 Europe Point of Care Molecular Diagnostics Technology Market Size by Type (2017-2022)
7.2.2 Europe Point of Care Molecular Diagnostics Technology Market Size by Type (2023-2028)
7.2.3 Europe Point of Care Molecular Diagnostics Technology Market Share by Type (2017-2028)
7.3 Europe Point of Care Molecular Diagnostics Technology Market Size by Application
7.3.1 Europe Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2022)
7.3.2 Europe Point of Care Molecular Diagnostics Technology Market Size by Application (2023-2028)
7.3.3 Europe Point of Care Molecular Diagnostics Technology Market Share by Application (2017-2028)
7.4 Europe Point of Care Molecular Diagnostics Technology Market Size by Country
7.4.1 Europe Point of Care Molecular Diagnostics Technology Market Size by Country (2017-2022)
7.4.2 Europe Point of Care Molecular Diagnostics Technology Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
8.2 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Type
8.2.1 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Share by Type (2017-2028)
8.3 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Application
8.3.1 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Share by Application (2017-2028)
8.4 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Region
8.4.1 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
9.2 Latin America Point of Care Molecular Diagnostics Technology Market Size by Type
9.2.1 Latin America Point of Care Molecular Diagnostics Technology Market Size by Type (2017-2022)
9.2.2 Latin America Point of Care Molecular Diagnostics Technology Market Size by Type (2023-2028)
9.2.3 Latin America Point of Care Molecular Diagnostics Technology Market Share by Type (2017-2028)
9.3 Latin America Point of Care Molecular Diagnostics Technology Market Size by Application
9.3.1 Latin America Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2022)
9.3.2 Latin America Point of Care Molecular Diagnostics Technology Market Size by Application (2023-2028)
9.3.3 Latin America Point of Care Molecular Diagnostics Technology Market Share by Application (2017-2028)
9.4 Latin America Point of Care Molecular Diagnostics Technology Market Size by Country
9.4.1 Latin America Point of Care Molecular Diagnostics Technology Market Size by Country (2017-2022)
9.4.2 Latin America Point of Care Molecular Diagnostics Technology Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
10.2 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Type
10.2.1 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Share by Type (2017-2028)
10.3 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Application
10.3.1 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Share by Application (2017-2028)
10.4 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Country
10.4.1 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point of Care Molecular Diagnostics Technology Introduction
11.1.4 Abbott Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.2.4 Accelerate Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.2.5 Accelerate Diagnostics Recent Developments
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Details
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.3.4 Ador Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.3.5 Ador Diagnostics Recent Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Point of Care Molecular Diagnostics Technology Introduction
11.4.4 Beckman Coulter Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.4.5 Beckman Coulter Recent Developments
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Details
11.5.2 Becton, Dickinson and Company Business Overview
11.5.3 Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Introduction
11.5.4 Becton, Dickinson and Company Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.5.5 Becton, Dickinson and Company Recent Developments
11.6 Binx Health
11.6.1 Binx Health Company Details
11.6.2 Binx Health Business Overview
11.6.3 Binx Health Point of Care Molecular Diagnostics Technology Introduction
11.6.4 Binx Health Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.6.5 Binx Health Recent Developments
11.7 Biocartis
11.7.1 Biocartis Company Details
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Point of Care Molecular Diagnostics Technology Introduction
11.7.4 Biocartis Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.7.5 Biocartis Recent Developments
11.8 bioMérieux
11.8.1 bioMérieux Company Details
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux Point of Care Molecular Diagnostics Technology Introduction
11.8.4 bioMérieux Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.8.5 bioMérieux Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Introduction
11.9.4 Bio-Rad Laboratories Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Bosch Healthcare Solutions
11.10.1 Bosch Healthcare Solutions Company Details
11.10.2 Bosch Healthcare Solutions Business Overview
11.10.3 Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Introduction
11.10.4 Bosch Healthcare Solutions Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.10.5 Bosch Healthcare Solutions Recent Developments
11.11 Curetis
11.11.1 Curetis Company Details
11.11.2 Curetis Business Overview
11.11.3 Curetis Point of Care Molecular Diagnostics Technology Introduction
11.11.4 Curetis Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.11.5 Curetis Recent Developments
11.12 Eurofins Scientific
11.12.1 Eurofins Scientific Company Details
11.12.2 Eurofins Scientific Business Overview
11.12.3 Eurofins Scientific Point of Care Molecular Diagnostics Technology Introduction
11.12.4 Eurofins Scientific Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.12.5 Eurofins Scientific Recent Developments
11.13 Genetic Signatures
11.13.1 Genetic Signatures Company Details
11.13.2 Genetic Signatures Business Overview
11.13.3 Genetic Signatures Point of Care Molecular Diagnostics Technology Introduction
11.13.4 Genetic Signatures Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.13.5 Genetic Signatures Recent Developments
11.14 Grifols
11.14.1 Grifols Company Details
11.14.2 Grifols Business Overview
11.14.3 Grifols Point of Care Molecular Diagnostics Technology Introduction
11.14.4 Grifols Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.14.5 Grifols Recent Developments
11.15 Hibergene Diagnostics
11.15.1 Hibergene Diagnostics Company Details
11.15.2 Hibergene Diagnostics Business Overview
11.15.3 Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.15.4 Hibergene Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.15.5 Hibergene Diagnostics Recent Developments
11.16 Lumos Diagnostics
11.16.1 Lumos Diagnostics Company Details
11.16.2 Lumos Diagnostics Business Overview
11.16.3 Lumos Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.16.4 Lumos Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.16.5 Lumos Diagnostics Recent Developments
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Point of Care Molecular Diagnostics Technology Introduction
11.17.4 Roche Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.17.5 Roche Recent Developments
11.18 Siemens
11.18.1 Siemens Company Details
11.18.2 Siemens Business Overview
11.18.3 Siemens Point of Care Molecular Diagnostics Technology Introduction
11.18.4 Siemens Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.18.5 Siemens Recent Developments
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Details
11.19.2 Thermo Fisher Scientific Business Overview
11.19.3 Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Introduction
11.19.4 Thermo Fisher Scientific Revenue in Point of Care Molecular Diagnostics Technology Business (2017-2022)
11.19.5 Thermo Fisher Scientific Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer